ASTRO

This page includes the latest news from the American Society of Radiation Oncology (ASTRO), including news and video coverage from the society's annual meeting. ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologist, physicists, radiation therapists, dosimetrists and other healthcare professionals who specialize in treating patients with radiation therapy. 

Results show Black women had significantly higher rates of radiation therapy recommendation compared to White women with similar biosignature scores
News | Radiation Therapy
PreludeDx Presents Comparative Data Analyzing Racial/Ethnic Radiation Therapy Treatment Recommendation Changes using DCISionRT

May 1, 2023 — Prelude Corporation (PreludeDx), a leader in molecular diagnostics and precision medicine for early-stage ...

Time May 01, 2023
arrow
American and European experts partner to issue first guideline on definitive local therapy options for non-small cell lung cancer (NSCLC) with limited extracranial metastases
News | Lung Imaging
ASTRO and ESTRO Issue Clinical Guideline on Local Therapy for Oligometastatic Lung Cancer

April 26, 2023 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) and European Society ...

Time April 26, 2023
arrow
ASTRO issued the following statement regarding the recent final rule from the CMS that revises the Medicare Advantage prior authorization process
News | Radiology Business
ASTRO Supports CMS’ Prior Authorization Reform for Medicare Advantage Plans

April 10, 2023 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Geraldine M ...

Time April 10, 2023
arrow
News | Radiation Oncology
Immunotherapy Costs Drive Increase in Medicare Spending for Outpatient Cancer Care at the End of Life

April 6, 2023 — A new study finds that recent increases in Medicare spending on outpatient cancer care at the end of ...

Time April 06, 2023
arrow
A new analysis of the U.S. radiation oncology workforce projects a relative balance between the supply of radiation oncologists and the demand for radiation therapy services through 2030. 
News | Radiation Oncology
Radiation Oncology Workforce Expected to Remain Stable Through 2030

March 8, 2023 — A new analysis of the U.S. radiation oncology workforce projects a relative balance between the supply ...

Time March 08, 2023
arrow
Age-based heuristics can lead to large differences in breast cancer treatment based on small differences in chronologic age, according to a new analysis of more than 500,000 patient records.
News | Radiation Therapy
Study Finds Large Gap in Breast Cancer Treatment Recommendations for Patients Aged 70 vs 69

January 31, 2023 — Age-based heuristics can lead to large differences in breast cancer treatment based on small ...

Time January 31, 2023
arrow
The Cancer Breakthroughs session of ASTRO2022 included research findings presented on behalf of the American Society of Clinical Oncology (ASCO) and the American Association of Physicists in Medicine (AAPM). Photo credit: ASTRO
Feature | ASTRO | Christine Book
ASTRO 2022 Shines Spotlight on “Cancer Breakthroughs” with AAPM, ASCO Research

The Imaging Technology News (ITN) editorial team is pleased to present the second portion of the American Society for ...

Time January 13, 2023
arrow
ASTRO's statement stresses that it is deeply disappointed in radiation oncology cuts and fears for stability of community-based cancer clinics
News | ASTRO
ASTRO Issues Statement in Response to 2023 Omnibus Appropriations Bill

December 20, 2022 — The American Society for Radiation Oncology (ASTRO) issued the following statement from ASTRO Board ...

Time December 20, 2022
arrow
Update to 2014 guidance outlines best practices for patient-centered, multidisciplinary care
News | Radiation Therapy
ASTRO Issues Updated Guideline on Radiation Therapy for Endometrial Cancer

December 8, 2022 — A newly updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides ...

Time December 08, 2022
arrow
Videos | ASTRO
VIDEO: Randomized Phase III Trial of Hypo Fractionated Whole Breast Irradiation

Dr. Frank A. Vicini, MD, FACR, FASTRO, FABS, who is a radiation oncologist with GenesisCare, discussed his findings from ...

Time November 09, 2022
arrow
An outstanding line-up of speakers and topics were featured at ASTRO22, including two dynamic keynote speakers focused on the meeting theme of AI & EI: Caring for the Patient in a Wireless World, in an effort to inform the bigger picture of the rapidly changing health care environment beyond radiation oncology. The conference was held Oct. 23-26 in San Antonio.
Gallery | ASTRO | By Melinda Taschetta-Millane
Photo Gallery of Technologies Showcased at ASTRO 2022

This is an image gallery of technologies on display on the expo floor at the 2022 American Society of Radiation Oncology ...

Time November 08, 2022
arrow
The MEVION S250-FIT Proton Therapy System (Photo: Business Wire)
News | Proton Therapy
Mevion Identifies Site for New Compact Proton Therapy System in Development

November 3, 2022 — Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation ...

Time November 03, 2022
arrow
News | Radiation Therapy
ViewRay Launches Phase III Pancreatic Cancer Study to Demonstrate Superior Overall Survival for Patients Receiving MRI-guided Ablative Radiation Therapy

November 2, 2022 — ViewRay, Inc. announced the launch of a phase III randomized controlled trial titled "Locally ...

Time November 02, 2022
arrow
18F-rhPSMA-7.3 PET image showing prostate cancer spread beyond the prostate region (Photo courtesy of Blue Earth Diagnostics)
News | PET Imaging
Blue Earth Diagnostics Announces Results on Clinical Factors Impacting Detection Rates from Phase 3 SPOTLIGHT Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Biochemical Recurrence of Prostate Cancer

November 2, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time November 02, 2022
arrow
Here is a rundown of what you and your colleagues found to be most interesting in the field of medical imaging during the month of October including #COVID-19 coverage
Feature | Radiology Business | By Melinda Taschetta-Millane
Top 10: Content that Caught Your Eye in October

Here is a rundown of what you and your colleagues found to be most interesting in the field of medical imaging during ...

Time November 01, 2022
arrow
First experience of proton Flash therapy in the clinic appears promising for future clinical trials
News | Proton Therapy
Varian and the Cincinnati Children's/University of Cincinnati Medical Center Proton Therapy Center Announce Promising Results from FAST-01, First-in-Human Clinical Trial of Flash Therapy

October 31, 2022 — Varian, a Siemens Healthineers company, and the Cincinnati Children's/University of Cincinnati ...

Time October 31, 2022
arrow
News | ASTRO | By Christine Book
“Cancer Breakthroughs” Session at ASTRO2022 Unveils Key Findings from ASCO, AAPM

October 31, 2022 — During the highly-anticipated “Cancer Breakthroughs” session at ASTRO2022, incoming ASTRO President ...

Time October 31, 2022
arrow
Chad Tang, MD
News | Prostate Cancer
Metastasis-Directed Radiation Therapy Plus Hormone Therapy Improves Progression-Free Survival for Men with Advanced Prostate Cancer

October 27, 2022 — Researchers from The University of Texas MD Anderson Cancer Center demonstrated that adding ...

Time October 27, 2022
arrow
CIVCO Radiotherapy has announced it is joining forces with Qfix, which provides patient positioning and immobilization devices.
News | ASTRO
CIVCO Radiotherapy Announces Integration with Qfix

October 26, 2022 — CIVCO Radiotherapy, a global provider of radiotherapy solutions, has announced it is joining forces ...

Time October 26, 2022
arrow
The oral presentation includes additional results from Blue Earth's Phase 3 SPOTLIGHT study evaluating the impact of clinical factors on the detection rate of 18F-rhPSMA-7.3 PET imaging in men with suspected prostate cancer recurrence based on elevated PSA following prior therapy
News | PET Imaging
Blue Earth Diagnostics Highlights Presentations on Axumin (Fluciclovine F 18) and Investigational 18F-rhPSMA-7.3 in Biochemically Recurrent Prostate Cancer

October 25, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time October 25, 2022
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now